$36.90+4.50% · 3M
Moving avg
1W+4.36%
1M+16.92%
3M+7.61%
6M+8.59%
YTD+19.22%
1Y+110.38%
3Y+286.39%
5Y+278.85%
52-week range
$15.5598% of range$37.35
Company health
Value1/6
Growth0/6
Profitability4/6
Health1/6
Dividend0/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (928%)
Risks
- Richly valued at 53.8x earnings
- Highly leveraged (debt is 2.2x equity)
Key statistics
Valuation
Market cap
$42.98B
Enterprise value
$53.22B
P/E ratio (TTM)
53.79x
P/S ratio (TTM)
2.31x
EV/EBITDA
17.40x
Per share & returns
EPS (TTM)
$0.62
Dividend yield
0.00%
Beta (1Y)
0.86
30-day change
+16.92%
Trading
Volume (24h)
2.54M
Previous close
$36.74
Shares outstanding
1.16B
About Teva Pharmaceutical Industries Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Symbol
TEVA
Teva Pharmaceutical Industries Limited is a large-cap healthcare company in the Drug Manufacturers - Specialty & Generic industry. Its shares are listed on NYSE under the ticker TEVA.
Frequently asked questions
What is Teva Pharmaceutical Industries Limited's market cap?
Teva Pharmaceutical Industries Limited (TEVA) has a market capitalization of $42.98B.
What is Teva Pharmaceutical Industries Limited's P/E ratio?
Teva Pharmaceutical Industries Limited trades at a price-to-earnings (P/E) ratio of 53.79.
What exchange does TEVA trade on?
TEVA trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,221.17+0.07%
$1.15T cap
Johnson & JohnsonJNJ
$261.41+0.21%
$629.97B cap
AbbVie Inc.ABBV
$250.64+0.75%
$442.82B cap
UnitedHealth Group IncorporatedUNH
$403.30-0.56%
$366.25B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.71+1.34%
$332.70B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap